Sighture Medical achieved significant international traction at the 91st CMEF (April 8-11, 2025), with its GAITNOVATE biomechanics systems, NeoVision infant retinal camera, and MedEye Simulated Eye drawing advanced partnership discussions from Canadian, German, and Indian healthcare leaders.
Next-Gen Clinical Solutions
GAITNOVATE-PRO
New Parkinson's gait tracking algorithms (CE submission Q3 2025)
Rehab-clinic integration modules
NeoVision 2.0 Infant Retinal Camera
150° ultra-widefield imaging + AI-based ROP risk scoring
HIPAA-compliant cloud collaboration for NICUs
MedEye Simulated Eye
New cataract complication training module
EU-focused anatomical variants for clinical training
Strategic Partnership Milestones
Canada: LOI with Ontario Orthopedic Network for 18 GAITNOVATE-III deployments
Germany: Framework agreement with Berlin Hospital Group for whole-hospital deployment
India: Apollo Hospitals integration pilot (diabetic care pathway: retinal + gait analysis)
Global Pipeline: 48 distributor agreements across 21 countries
"Our Simulated Eye bridges theoretical training and clinical execution," stated Dr. Zhang Wei, Chief Medical Officer. "When combined with GAITNOVATE's predictive analytics, we're creating proactive care ecosystems from pediatrics to geriatrics."
Commercialization Roadmap
June 2025: First Canadian GAITNOVATE-PRO installations
September 2025: NeoVision 2.0 EU-MDR certification
2026: Simulated Eye localization for EU anatomical standards
*ISO 13485-certified with 36 patents. Now serving 53 countries through sensor-driven medical innovations.*
English 
